Effect of in Vitro Haemolysis on Serum High Sensitivity Troponin T Measurements From Patients in Accident & Emergency
Investigation Into the Effect of in Vitro Haemolysis on Serum High Sensitivity Troponin T Measurement, and the Determination of an Acceptable Haemolysis Index Limit
1 other identifier
observational
61
1 country
1
Brief Summary
This study will be investigating how a common blood test for identifying heart damage (Troponin T) is affected by red blood cell damage in the blood sample (Haemolysis). It is already known that damage to the red blood cells during or after blood sample collection can cause falsely low test results however the exact amount is not clear. Some previous studies suggest that a much higher amount of red blood cell damage could be allowable when reporting the test results. This study will mimic the type of red blood cell damage that occurs in the hospital and determine what degree of damage or 'haemolysis' causes a significant reduction in the test result and therefore determine an allowable limit for safely reporting the test result. The results of this study may help provide an evidence based approach to improving current practice and may lead to fewer rejected blood samples, fewer repeat tests, improved A\&E treatment times, general cost savings and an improved service to patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2017
CompletedFirst Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
February 20, 2018
CompletedFebruary 20, 2018
February 1, 2018
3 months
February 5, 2018
February 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference in measured hs-cTnT between baseline and the haemolysis groups.
Day one
Secondary Outcomes (1)
The Percentage change in hs-cTnT due to haemolysis at five groups of different troponin T levels.
Day one
Eligibility Criteria
Adult patients attending Poole emergency department having High Sensitivity Troponin T measurements performed on their blood as part of their medical investigations.
You may qualify if:
- Adult patients attending Poole emergency department having High Sensitivity Troponin T measurements performed on their blood as part of their medical investigations.
You may not qualify if:
- Serum samples with Haemolysis Index \>20.
- Serum High sensitivity Troponin T result \<5 ng/l and \>100 ng/l
- Patients lacking capacity to give verbal consent.
- Under 18 years of age.
- Patient has previously been approached about this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poole Hospital NHSFT
Poole, Dorset, BH15 2JB, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2018
First Posted
February 20, 2018
Study Start
September 9, 2017
Primary Completion
December 6, 2017
Study Completion
December 6, 2017
Last Updated
February 20, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share